BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28940455)

  • 21. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
    Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
    J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of tumor markers series of hydrothorax in differential diagnosis of pleural effusion].
    Liu YQ; Zhang HL; Gao WJ; Lan X; Yuan BJ; Zou JM
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jan; 26(1):34-8. PubMed ID: 18302890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a novel diagnostic nomogram model based on tumor markers for assessing cancer risk of pulmonary lesions: A multicenter study in Chinese population.
    Du Q; Yan C; Wu SG; Zhang W; Huang C; Yao Y; Wang L; Zhang Q; Liu Q; Guan J; Hou Y; Li Z; Soh A; Beshiri A; Wang Q; Li X; Zheng Y; Wang H
    Cancer Lett; 2018 Apr; 420():236-241. PubMed ID: 29412152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer.
    Wang B; He YJ; Tian YX; Yang RN; Zhu YR; Qiu H
    Asian Pac J Cancer Prev; 2014; 15(22):9611-4. PubMed ID: 25520076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fusion of quantitative imaging features and serum biomarkers to improve performance of computer-aided diagnosis scheme for lung cancer: A preliminary study.
    Gong J; Liu JY; Jiang YJ; Sun XW; Zheng B; Nie SD
    Med Phys; 2018 Dec; 45(12):5472-5481. PubMed ID: 30317652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnostic value of serum tumor markers in differentiating malignant from benign solitary pulmonary nodules].
    Ni LF; Liu XM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 46(5):707-10. PubMed ID: 25331391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of preoperative prediction factors of tumor subtypes for patients with solitary ground-glass opacity pulmonary nodules.
    Li M; Wang Y; Chen Y; Zhang Z
    J Cardiothorac Surg; 2018 Jan; 13(1):9. PubMed ID: 29343293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.
    Zhang L; Liu D; Li L; Pu D; Zhou P; Jing Y; Yu H; Wang Y; Zhu Y; He Y; Li Y; Zhao S; Qiu Z; Li W
    BMC Cancer; 2017 Feb; 17(1):96. PubMed ID: 28152979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical Significance of Tumor Marker Detection in Patients 
with Advanced Squamous Cell Carcimoma of the Lung].
    Liang P; Li J
    Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):641-647. PubMed ID: 27760591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer.
    Holdenrieder S; von Pawel J; Dankelmann E; Duell T; Faderl B; Markus A; Siakavara M; Wagner H; Feldmann K; Hoffmann H; Raith H; Nagel D; Stieber P
    Clin Cancer Res; 2008 Dec; 14(23):7813-21. PubMed ID: 19047109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer.
    Molina R; Marrades RM; Augé JM; Escudero JM; Viñolas N; Reguart N; Ramirez J; Filella X; Molins L; Agustí A
    Am J Respir Crit Care Med; 2016 Feb; 193(4):427-37. PubMed ID: 26465739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
    Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
    J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Establishment and Verification of A Novel Predictive Model of Malignancy
for Non-solid Pulmonary Nodules].
    Xiao F; Yu Q; Zhang Z; Liu D; Liang C
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):26-33. PubMed ID: 30674390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
    Yang Q; Zhang P; Wu R; Lu K; Zhou H
    Dis Markers; 2018; 2018():2082840. PubMed ID: 30364165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiplexed Serum Biomarkers for the Detection of Lung Cancer.
    Ma S; Wang W; Xia B; Zhang S; Yuan H; Jiang H; Meng W; Zheng X; Wang X
    EBioMedicine; 2016 Sep; 11():210-218. PubMed ID: 27575387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of lung cancer based on serum biomarkers by gene expression programming methods.
    Yu Z; Chen XZ; Cui LH; Si HZ; Lu HJ; Liu SH
    Asian Pac J Cancer Prev; 2014; 15(21):9367-73. PubMed ID: 25422226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Validation of a Protein Biomarker Panel for Non-Small Cell Lung Cancer.
    Jung YJ; Oh IJ; Kim Y; Jung JH; Seok M; Lee W; Park CK; Lim JH; Kim YC; Kim WS; Choi CM
    J Korean Med Sci; 2018 Dec; 33(53):e342. PubMed ID: 30595683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An elevated progastrin-releasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival.
    Korse CM; Taal BG; Bonfrer JMG; Vincent A; van Velthuysen ML; Baas P
    Ann Oncol; 2011 Dec; 22(12):2625-2630. PubMed ID: 21415235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Heat Shock Protein 70 Is a Novel Biomarker for Early Diagnosis of Lung Cancer.
    Tang T; Yang C; Brown HE; Huang J
    Dis Markers; 2018; 2018():6184162. PubMed ID: 30245753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.